RNAi screen identifies essential regulators of human brain metastasis-initiating cells
Brain metastases (BM) are the most common brain tumor in adults and are a leading cause
of cancer mortality. Metastatic lesions contain subclones derived from their primary lesion …
of cancer mortality. Metastatic lesions contain subclones derived from their primary lesion …
[PDF][PDF] Patient-derived models of brain metastases recapitulate human disseminated disease
Dissemination of cancer cells from primary tumors to the brain occurs in many cancer
patients, increasing morbidity and death. There is an unmet medical need to develop …
patients, increasing morbidity and death. There is an unmet medical need to develop …
Therapeutic targeting of the premetastatic stage in human lung-to-brain metastasis
Brain metastases (BM) result from the spread of primary tumors to the brain and are a
leading cause of cancer mortality in adults. Secondary tissue colonization remains the main …
leading cause of cancer mortality in adults. Secondary tissue colonization remains the main …
A cancer stem cell model for studying brain metastases from primary lung cancer
SM Nolte, C Venugopal, N McFarlane… - Journal of the …, 2013 - academic.oup.com
Background Brain metastases are most common in adults with lung cancer, predicting
uniformly poor patient outcome, with a median survival of only months. Despite their …
uniformly poor patient outcome, with a median survival of only months. Despite their …
[HTML][HTML] Deciphering brain metastasis stem cell properties from colorectal cancer highlights specific stemness signature and shared molecular features
A Desette, PO Guichet, S Emambux… - Cellular and Molecular …, 2023 - Elsevier
Background & Aims Brain metastases (BMs) from colorectal cancer (CRC) are associated
with significant morbidity and mortality, with chemoresistance and short overall survival …
with significant morbidity and mortality, with chemoresistance and short overall survival …
SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition
L Miao, Y Wang, H Xia, C Yao, H Cai, Y Song - … and biophysical research …, 2013 - Elsevier
Lung cancer is the leading cause of cancer related death worldwide and the prognosis is
still poor with 5-year survival of approximately 15%. Metastasis is the leading cause of death …
still poor with 5-year survival of approximately 15%. Metastasis is the leading cause of death …
[PDF][PDF] Cellular architecture of human brain metastases
H Gonzalez, W Mei, I Robles, C Hagerling, BM Allen… - Cell, 2022 - cell.com
Brain metastasis (BrM) is the most common form of brain cancer, characterized by
neurologic disability and an abysmal prognosis. Unfortunately, our understanding of the …
neurologic disability and an abysmal prognosis. Unfortunately, our understanding of the …
[HTML][HTML] Brain metastasis-initiating cells: survival of the fittest
M Singh, B Manoranjan, S Mahendram… - International journal of …, 2014 - mdpi.com
Brain metastases (BMs) are the most common brain tumor in adults, developing in about
10% of adult cancer patients. It is not the incidence of BM that is alarming, but the poor …
10% of adult cancer patients. It is not the incidence of BM that is alarming, but the poor …
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
BI Bassey-Archibong… - Proceedings of the …, 2023 - National Acad Sciences
Brain metastases (BM) are the most common brain neoplasm in adults. Current BM
therapies still offer limited efficacy and reduced survival outcomes, emphasizing the need for …
therapies still offer limited efficacy and reduced survival outcomes, emphasizing the need for …
Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications
CY Wu, JJ Hung, KJ Wu - Clinical and Experimental …, 2012 - Wiley Online Library
Cancer metastasis is the major cause of cancer‐related death despite significant
improvements in multimodal cancer therapy. Epithelial–mesenchymal transition (EMT), a …
improvements in multimodal cancer therapy. Epithelial–mesenchymal transition (EMT), a …